Pharma Journalist - Page 8 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

Agios Expands Rare Disease Portfolio with Cevidoplenib Deal

Servier Acquires Edgewise Muscular Dystrophy Business

FDA Reviews Camzyos for Adolescent Heart Disease

EU Approves Opdivo Combo for Advanced Hodgkin Lymphoma

Phase 3 Data Show Functional Cure Potential in Hepatitis B

FDA Grants Priority Review to Sanofi’s Gaucher Disease Drug

Pfizer and Innovent Partner on $10.5 Billion Cancer Drug Collaboration

GSK Drug Bepirovirsen Shows Promise in Redefining Chronic Hepatitis B Treatment

Novo Study Highlights Persistent Cardiovascular Inflammation Risk

SK bioscience, Colombia Partner on Vaccine Manufacturing Initiative